STRATA Skin Sciences (SSKN) EPS (Basic) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.88% |
| Sep 30, 2025 | -55.18% |
| Jun 30, 2025 | -65.46% |
| Mar 31, 2025 | -76.23% |
| Dec 31, 2024 | -158.31% |
| Sep 30, 2024 | -76.23% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -20.11% |
| Dec 31, 2023 | -123.69% |
| Sep 30, 2023 | -71.88% |
| Jun 30, 2023 | -66.66% |
| Mar 31, 2023 | 7.79% |
| Dec 31, 2022 | -14.88% |
| Sep 30, 2022 | 63.51% |
| Jun 30, 2022 | -15.50% |
| Mar 31, 2022 | 47.94% |
| Dec 31, 2021 | 40.73% |
| Sep 30, 2021 | 51.03% |
| Jun 30, 2021 | -34.02% |
| Mar 31, 2021 | 36.90% |
| Dec 31, 2020 | -15.63% |
| Sep 30, 2020 | 50.08% |
| Jun 30, 2020 | 44.74% |
| Mar 31, 2020 | 51.52% |
| Dec 31, 2019 | 61.22% |
| Sep 30, 2019 | 41.56% |
| Jun 30, 2019 | -17.61% |
| Mar 31, 2019 | 52.36% |
| Dec 31, 2018 | 15.11% |
| Sep 30, 2018 | 58.97% |
| Jun 30, 2018 | 47.29% |
| Mar 31, 2018 | 6.73% |
| Dec 31, 2017 | 84.62% |
| Sep 30, 2017 | -93.74% |
| Jun 30, 2017 | 47.58% |
| Mar 31, 2017 | -57.30% |
| Dec 31, 2016 | -19.25% |
| Sep 30, 2016 | -24.23% |
| Jun 30, 2016 | 26.69% |
| Mar 31, 2016 | -28.47% |
| Dec 31, 2015 | 22.10% |
| Sep 30, 2015 | -45.18% |
| Jun 30, 2015 | -37.14% |